Emergent Biosolutions, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
30.50
|
|
Average Rating
|
3.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
5
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.06
|
-1.27
|
-1.21
|
-2016.67%
|
|
2022-06-30
|
0.38
|
-0.86
|
-1.24
|
-326.32%
|
|
2022-03-31
|
0.13
|
0.18
|
0.05
|
38.46%
|
|
2021-12-31
|
4.27
|
4.50
|
0.23
|
5.39%
|
|
2021-09-30
|
2.35
|
-0.36
|
-2.71
|
-115.32%
|
|
2021-06-30
|
1.54
|
0.33
|
-1.21
|
-78.57%
|
|
2021-03-31
|
1.12
|
1.53
|
0.41
|
36.61%
|
|
2020-12-31
|
3.19
|
3.67
|
0.48
|
15.05%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.95
|
|
2021-12-31
|
6.00
|
|
2020-12-31
|
7.85
|
|
2019-12-31
|
2.77
|
|
2018-12-31
|
2.34
|
|
2017-12-31
|
1.89
|
|
2016-12-31
|
1.30
|
|
2015-12-31
|
1.47
|
|
2014-12-31
|
1.06
|
|
2013-12-31
|
0.84
|
|
2012-12-31
|
0.81
|
|
2011-12-31
|
0.60
|
|
2010-12-31
|
1.56
|
|
2009-12-31
|
0.99
|
|
2008-12-31
|
0.69
|
|
2007-12-31
|
0.76
|
|
2006-12-31
|
1.03
|